Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Advances in Cancer Research|February 3, 2015
Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studiesEduardo E Chufan, Hong-May Sim, Suresh V Ambudkar
Biochemical Pharmacology|August 23, 2011
In vitro and in vivo modulation of ABCG2 by functionalized aurones and structurally related analogsHong-May Sim, Chung-Pu Wu, Suresh V Ambudkar, et al.
Biochemistry|September 24, 2013
Conserved Walker A cysteines 431 and 1074 in human P-glycoprotein are accessible to thiol-specific agents in the apo and ADP-vanadate trapped conformationsHong-May Sim, Jaya Bhatnagar, Eduardo E Chufan, et al.
Advances in Experimental Medicine and Biology|October 2, 2019
ABC Transporter-Mediated Multidrug-Resistant CancerHaneen Amawi, Hong-May Sim, Amit K Tiwari, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 30, 2008
Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein)Hong-May Sim, Chong-Yew Lee, Pui Lai Rachel Ee, et al.
Chemmedchem|February 9, 2011
Aurones as modulators of ABCG2 and ABCB1: synthesis and structure-activity relationshipsHong May Sim, Ker Yun Loh, Wee Kiang Yeo, et al.
Bioorganic & Medicinal Chemistry Letters|July 27, 2011
Synthesis and antimicrobial activity of N¹-benzyl or N¹-benzyloxy-1,6-dihydro-1,3,5-triazine-2,4-diaminesXiang Ma, Soo-Tong Tan, Chai-Ling Khoo, et al.
Plos One|December 19, 2013
Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1)Eduardo E Chufan, Khyati Kapoor, Hong-May Sim, et al.
BMC Biology|November 11, 2017
A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53Jin Huei Wong, Mohammad Alfatah, Mei Fang Sin, et al.
Biochemical Pharmacology|November 17, 2012
Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cellsChung-Pu Wu, Hong-May Sim, Yang-Hui Huang, et al.
Pageof 2